Skip to content
Catalyst

PapersPMID:34203925

Effects of Ingesting Fucoidan Derived from Cladosiphon okamuranus Tokida on Human NK Cells: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Pilot Study.

Marine drugs2021The record ↗

findings
3
compound
1
endpoints
3
PMID:34203925
  1. Finding, moderate evidenceno difference foundBlood haemoglobin concentration
  2. Finding, moderate evidenceno difference foundHaematocrit
  3. Finding, limited evidenceno difference foundTotal leukocyte count
Study, every finding
RCT · 39 participants
Dose studied, every finding
two bottles a day, 3 g/day of fucoidan, oral beverage
Population, every finding
Healthy Japanese men and women aged 20 to 65 years, 39 completers; safety blood tests over the study period, no timepoint stated in the sentence

No finding here moved its endpoint.

Study record

Design
randomised controlled trial
Species
human
Population
Healthy men and women aged 20 to 65 years; fucoidan from Okinawa mozuku (Cladosiphon okamuranus, mean molecular weight 73.4 kDa) as a beverage versus placebo beverage
Participants
40
Comparator
placebo
Duration
84 days
Endpoints measured
17